Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay

被引:30
作者
Opalka, D
Pessi, A
Bianchi, E
Ciliberto, G
Schleif, W
McElhaugh, M
Danzeisen, R
Geleziunas, R
Miller, M
Eckert, DM
Bramhill, D
Joyce, J
Cook, J
Magilton, W
Shiver, J
Emini, E
Esser, MT
机构
[1] Merck Res Labs, Vaccine & Biol Res, MRL Wayne, Wayne, PA 19087 USA
[2] IRBM P Angeletti, Pomezia, RM, Italy
[3] Merck Res Labs, Vaccine & Biol Res, West Point, PA 19486 USA
[4] Merck Res Labs, Biol Chem, West Point, PA 19486 USA
关键词
human immunodeficiency virus; multiplexed; neutralizing antibody; epitope-mapping; luminex;
D O I
10.1016/j.jim.2004.01.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A fluorescence-based, multiplexed, antibody-binding and mapping assay was developed to characterize antibody responses in HIV-1-infected individuals to the ectodomain of the HIV-1 gp41 envelope glycoprotein. The antigen panel included intact recombinant gp41, the fusion peptide region, the polar region, the N-heptad region, the C-heptad region as well as overlapping epitopes in the 2F5 and 4E10 monoclonal antibody-bin ding regions. The panel included both native and constrained peptides specifically designed to mimic putative gp41 prefusion and fusion intermediates. The results of these analyses revealed a broad pattern of immune responses against the test antigens, suggesting that none of these gp41 regions are immunologically silent. The HIV-1-positive sera were also evaluated using infectivity inhibition assays. No correlation was evident between the breadth or magnitude of specific anti-gp41 reactivities and virus neutralization potency. These evaluations demonstrated the substantial potential of the multiplexed antibody binding and mapping assay for rapid and sensitive analysis of complex antibody responses. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:49 / 65
页数:17
相关论文
共 35 条
[1]   Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].
Baba, TW ;
Liska, V ;
Hofmann-Lehmann, R ;
Vlasak, J ;
Xu, WD ;
Ayehunie, S ;
Cavacini, LA ;
Posner, MR ;
Katinger, H ;
Stiegler, G ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Lu, YC ;
Wright, JE ;
Chou, TC ;
Ruprecht, RM .
NATURE MEDICINE, 2000, 6 (02) :200-206
[2]   Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion [J].
Barbato, G ;
Bianchi, E ;
Ingallinella, P ;
Hurni, WH ;
Miller, MD ;
Cilibertol, G ;
Cortese, R ;
Bazzo, R ;
Shiver, JW ;
Pessi, A .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 330 (05) :1101-1115
[3]   VIRUS ENVELOPE PROTEIN OF HTLV-III REPRESENTS MAJOR TARGET ANTIGEN FOR ANTIBODIES IN AIDS PATIENTS [J].
BARIN, F ;
MCLANE, MF ;
ALLAN, JS ;
LEE, TH ;
GROOPMAN, JE ;
ESSEX, M .
SCIENCE, 1985, 228 (4703) :1094-1096
[4]  
BIANCHI E, 2003, PEPTIDES 2002, P682
[5]   A monomeric 310-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41 [J].
Biron, Z ;
Khare, S ;
Samson, AO ;
Hayek, Y ;
Naider, F ;
Anglister, J .
BIOCHEMISTRY, 2002, 41 (42) :12687-12696
[6]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[7]   Biophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1 - Implications on viral fusion mechanism [J].
Chang, DK ;
Cheng, SF ;
Trivedi, VD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (09) :5299-5309
[8]   Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket [J].
Eckert, DM ;
Malashkevich, VN ;
Hong, LH ;
Carr, PA ;
Kim, PS .
CELL, 1999, 99 (01) :103-115
[9]   Mechanisms of viral membrane fusion and its inhibition [J].
Eckert, DM ;
Kim, PS .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :777-810
[10]   Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region [J].
Eckert, DM ;
Kim, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11187-11192